These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 6358180)

  • 1. Non-specific host defence stimulation and antibiotic-resistant infection.
    Lamont PM; Trachtenberg LS; West CS; Polk HC
    J Antimicrob Chemother; 1983 Oct; 12 Suppl C():117-22. PubMed ID: 6358180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stimulation of nonspecific resistance to infection induced by muramyl dipeptide analogs substituted in the gamma-carboxyl group and evaluation of N alpha-muramyl dipeptide-N epsilon-stearoyllysine.
    Matsumoto K; Otani T; Une T; Osada Y; Ogawa H; Azuma I
    Infect Immun; 1983 Mar; 39(3):1029-40. PubMed ID: 6341226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Muramyl dipeptide-induced enhancement of phagocytosis of antibiotic pretreated Escherichia coli by macrophages.
    Friedman H; Warren G
    Proc Soc Exp Biol Med; 1984 Sep; 176(4):366-70. PubMed ID: 6379653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-specific stimulation of host defenses against a bacterial challenge in malnourished hosts.
    Galland RB; Polk HC
    Br J Surg; 1982 Nov; 69(11):665-8. PubMed ID: 6751460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of muramyl dipeptide and clindamycin in a murine abdominal abscess model.
    Cheadle WG; Brown GL; Lamont PM; Trachtenberg LS; Polk HC
    J Surg Res; 1986 Sep; 41(3):319-25. PubMed ID: 3762139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stimulation of non-specific resistance to infection by muroctasin.
    Otani T; Une T; Osada Y
    Arzneimittelforschung; 1988 Jul; 38(7A):969-76. PubMed ID: 3056426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of muramyl dipeptide in the therapy of established experimental bacterial infection.
    Ausobsky JR; Scuitto M; Trachtenberg LS; Polk HC
    Br J Exp Pathol; 1984 Feb; 65(1):1-9. PubMed ID: 6365142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The nucleotide-binding oligomerization domain-containing-2 ligand muramyl dipeptide enhances phagocytosis and intracellular killing of Escherichia coli K1 by Toll-like receptor agonists in microglial cells.
    Ribes S; Adam N; Schütze S; Regen T; Redlich S; Janova H; Borisch A; Hanisch UK; Nau R
    J Neuroimmunol; 2012 Nov; 252(1-2):16-23. PubMed ID: 22889567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancement of the local inflammatory response to bacterial infection by muramyl dipeptide.
    Lamont PM; Schrodt GR; Galland RB; Kaufman CM; Cheadle WG; Polk HC
    Br J Exp Pathol; 1984 Jun; 65(3):319-25. PubMed ID: 6743532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonspecific enhancement of resistance to local bacterial infection in starved mice.
    Galland RB; Trachtenberg LS; Rynerson N; Polk HC
    Arch Surg; 1982 Feb; 117(2):161-4. PubMed ID: 7034676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of muramyl dipeptide and lead acetate on carbon clearance and endotoxin-induced mortality in mice.
    Cheadle WG; Ausobsky JR; Trachtenberg LS; Lamont P; Polk HC
    Am Surg; 1986 Nov; 52(11):613-7. PubMed ID: 3535600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of muramyl dipeptide and core body temperature on peritoneal bacterial clearance.
    Stellato TA; Townsend MC; Gordon N; Danziger LH; Galloway P; Hawkins NL; Fry DE
    Arch Surg; 1988 Apr; 123(4):465-9. PubMed ID: 3279936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Activation of the production of the tumor-necrosis factor by the combined action of lipopolysaccharide and muramyl dipeptide in vitro and in vivo].
    Fuks BB; Rakhmilevich AL; Pimenov AA; Dubrovskaia AG
    Biull Eksp Biol Med; 1987 Oct; 104(10):497-9. PubMed ID: 3315036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo and in vitro stimulation of nonspecific immunity by the beta-D-p-aminophenyl glycoside of N-acetylmuramyl-L-alanyl-D-isoglutamine and an oligomer prepared by cross-linking with glutaraldehyde.
    Parant M; Damais C; Audibert F; Parant F; Chedid L; Sache E; Lefrancier P; Choay J; Lederer E
    J Infect Dis; 1978 Sep; 138(3):378-86. PubMed ID: 100563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of synthetic adjuvants on nonspecific resistance to infections.
    Parant M
    Int J Immunopharmacol; 1994; 16(5-6):445-9. PubMed ID: 7927991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonspecific enhancement of resistance to bacterial infection: evidence of an effect supplemental to antibiotics.
    Polk HC; Galland RB; Ausobsky JR
    Ann Surg; 1982 Oct; 196(4):436-41. PubMed ID: 7125729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of subminimal inhibitory concentrations of clindamycin and Escherichia coli: effects on adhesion and polymorphonuclear leukocyte function.
    Bassaris HP; Lianou PE; Papavassiliou JT
    J Antimicrob Chemother; 1984 Apr; 13(4):361-7. PubMed ID: 6373717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stimulatory effects of muramyl dipeptide upon neutrophils isolated from a local bacterial infection.
    Lamont PM; Maier KG; Melton L; Polk HC
    Br J Exp Pathol; 1987 Oct; 68(5):655-61. PubMed ID: 3318904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential feeding responses to bacterial lipopolysaccharide and muramyl dipeptide.
    Langhans W; Balkowski G; Savoldelli D
    Am J Physiol; 1991 Sep; 261(3 Pt 2):R659-64. PubMed ID: 1887952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CARD15 variants determine a disturbed early response of monocytes to adherent-invasive Escherichia coli strain LF82 in Crohn's disease.
    Peeters H; Bogaert S; Laukens D; Rottiers P; De Keyser F; Darfeuille-Michaud A; Glasser AL; Elewaut D; De Vos M
    Int J Immunogenet; 2007 Jun; 34(3):181-91. PubMed ID: 17504508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.